- Home
- ATNF vs TTNP Comparison
ATNF vs TTNP Comparison
Compare ATNF & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- TTNP
- Stock Information
- Founded
- ATNF 2016
- TTNP 1991
- Country
- ATNF United States
- TTNP United States
- Employees
- ATNF N/A
- TTNP N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATNF Health Care
- TTNP Health Care
- Exchange
- ATNF Nasdaq
- TTNP Nasdaq
- Market Cap
- ATNF 3.8M
- TTNP 3.4M
- IPO Year
- ATNF N/A
- TTNP 1996
- Fundamental
- Price
- ATNF $1.05
- TTNP $4.65
- Analyst Decision
- ATNF
- TTNP
- Analyst Count
- ATNF 0
- TTNP 0
- Target Price
- ATNF N/A
- TTNP N/A
- AVG Volume (30 Days)
- ATNF 43.3K
- TTNP 81.0K
- Earning Date
- ATNF 05-15-2025
- TTNP 05-14-2025
- Dividend Yield
- ATNF N/A
- TTNP N/A
- EPS Growth
- ATNF N/A
- TTNP N/A
- EPS
- ATNF N/A
- TTNP N/A
- Revenue
- ATNF N/A
- TTNP N/A
- Revenue This Year
- ATNF N/A
- TTNP N/A
- Revenue Next Year
- ATNF N/A
- TTNP N/A
- P/E Ratio
- ATNF N/A
- TTNP N/A
- Revenue Growth
- ATNF N/A
- TTNP N/A
- 52 Week Low
- ATNF $0.66
- TTNP $3.03
- 52 Week High
- ATNF $17.75
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- ATNF 49.77
- TTNP 53.37
- Support Level
- ATNF $1.01
- TTNP $4.16
- Resistance Level
- ATNF $1.10
- TTNP $5.12
- Average True Range (ATR)
- ATNF 0.08
- TTNP 0.44
- MACD
- ATNF -0.01
- TTNP -0.01
- Stochastic Oscillator
- ATNF 35.29
- TTNP 51.54
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.